CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Reply: Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist? Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure Dapagliflozin for treating chronic heart failure with reduced ejection fraction Coronary Atherosclerotic Precursors of Acute Coronary Syndromes

LetterVolume 12, Issue 8, April 2019

JOURNAL:JACC Cardiovasc Interv. Article Link

Reply: Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?

Zhang H, Chen SL. Keywords: pulmonary artery denervation; pulmonary hypertension

LINK

Please click on the "Article Link" on top right to get further access to this letter.